{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T04:05:06Z","timestamp":1747368306064,"version":"3.40.5"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T00:00:00Z","timestamp":1747267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T00:00:00Z","timestamp":1747267200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"DOI":"10.1186\/s12985-025-02762-2","type":"journal-article","created":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T11:39:20Z","timestamp":1747309160000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparison of dried blood spot (DBS) and plasma HIV-1 viral load measurements using Roche COBAS AmpliPrep\/COBAS TaqMan assay, Northwest Ethiopia"],"prefix":"10.1186","volume":"22","author":[{"given":"Firehiwot","family":"Kebede","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Getu","family":"Girmay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gezahegn","family":"Bewket","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muluneh","family":"Assefa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadelo","family":"Wondmagegn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mulualem","family":"Lemma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nega","family":"Berhane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,15]]},"reference":[{"issue":"2","key":"2762_CR1","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.clindermatol.2024.02.001","volume":"42","author":"S Payagala","year":"2024","unstructured":"Payagala S, Pozniak A. The global burden of HIV. Clin Dermatol. 2024;42(2):119\u201327.","journal-title":"Clin Dermatol"},{"key":"2762_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-020-08988-9","volume":"20","author":"PN Gona","year":"2020","unstructured":"Gona PN, Gona CM, Ballout S, Rao SR, Kimokoti R, Mapoma CC, et al. Burden and changes in HIV\/AIDS morbidity and mortality in Southern Africa development community countries, 1990\u20132017. BMC Public Health. 2020;20:1\u201314.","journal-title":"BMC Public Health"},{"key":"2762_CR3","unstructured":"Organization WH, HIV, Geneva. AIDS. World Health Organization.; 2024 [updated 22 July 2024. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hiv-aids"},{"issue":"12","key":"2762_CR4","doi-asserted-by":"publisher","first-page":"e807","DOI":"10.1016\/S2352-3018(24)00212-1","volume":"11","author":"AZM Carter","year":"2024","unstructured":"Carter AZM, Tram KH, Walters MK, Jahagirdar D, Brewer ED, et al. Global, regional, and National burden of HIV\/AIDS, 1990\u20132021, and forecasts to 2050, for 204 countries and territories: the global burden of disease study 2021. Lancet HIV. 2024;11(12):e807\u201322.","journal-title":"Lancet HIV"},{"key":"2762_CR5","doi-asserted-by":"crossref","unstructured":"al. FPLSZCRECHA-TCe. Progress in scale up of HIV viral load testing in select sub-Saharan African countries 2016\u20132018. PLoS ONE. 2023;18(3):e0282652.","DOI":"10.1371\/journal.pone.0282652"},{"key":"2762_CR6","doi-asserted-by":"crossref","unstructured":"al. DJSYLRBENJNKe. Point-of-care viral load testing to manage HIV viremia during the rollout of dolutegravir-based ART in South Africa: a randomized feasibility study (POwER). Acquir Immune Defic Syndr. 2023;93(5):403\u201312.","DOI":"10.1097\/QAI.0000000000003212"},{"issue":"8","key":"2762_CR7","doi-asserted-by":"publisher","first-page":"e1004076","DOI":"10.1371\/journal.pmed.1004076","volume":"19","author":"LCS Vojnov","year":"2022","unstructured":"Vojnov LCS, Zeh C, Markby J, Boeras D, Prescott MR, et al. The performance of using dried blood spot specimens for HIV-1 viral load testing: a systematic review and meta-analysis. PLoS Med. 2022;19(8):e1004076.","journal-title":"PLoS Med"},{"issue":"1","key":"2762_CR8","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1742-6405-4-11","volume":"4","author":"SE Langford","year":"2007","unstructured":"Langford SE, Ananworanich J, Cooper DA. Predictors of disease progression in HIV infection: A review. AIDS Res Ther. 2007;4(1):11.","journal-title":"AIDS Res Ther"},{"issue":"1","key":"2762_CR9","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s10461-023-04136-7","volume":"28","author":"AA DMHSMJA","year":"2024","unstructured":"DMHSMJA AA. Examining concordance between Self-Report and biomedical HIV viral load data: A scoping review. AIDS Behav. 2024;28(1):93\u2013104.","journal-title":"AIDS Behav"},{"key":"2762_CR10","unstructured":"World Health Organization. Working for health 2022\u20132030 action plan; world health organization. Geneva, Switzerland; 2022."},{"key":"2762_CR11","doi-asserted-by":"crossref","unstructured":"al. FLG-FPFAAE-SWSOGPe. Achieving the 95 95 95 targets for all: a pathway to ending aidsachieving the 95 95 95 targets for all: a pathway to ending AIDS. PLoS ONE. 2022;17(8):e0272405.","DOI":"10.1371\/journal.pone.0272405"},{"issue":"7","key":"2762_CR12","doi-asserted-by":"publisher","first-page":"e0219381","DOI":"10.1371\/journal.pone.0219381","volume":"14","author":"D Hardie","year":"2019","unstructured":"Hardie D, Korsman S, Ameer S, Vojnov L, Hsiao NY. Reliability of plasma HIV viral load testing beyond 24 hours: insights gained from a study in a routine diagnostic laboratory. PLoS ONE. 2019;14(7):e0219381.","journal-title":"PLoS ONE"},{"issue":"20","key":"2762_CR13","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1001\/jama.286.20.2560","volume":"286","author":"AN Phillips","year":"2001","unstructured":"Phillips AN, Staszewski S, Weber R, Kirk O, Francioli P, Miller V, et al. Swiss HIV cohort study. HIV viral load response to antiretroviral therapy according to the baseline CD4 cell count and viralload. JAMA. 2001;286(20):2560\u20137.","journal-title":"JAMA"},{"issue":"4","key":"2762_CR14","doi-asserted-by":"publisher","first-page":"e2052","DOI":"10.1002\/rmv.2052","volume":"29","author":"G Van Zyl","year":"2019","unstructured":"Van Zyl G, Maritz J, Newman H, Preiser W. Lessons in diagnostic virology: expected and unexpected sources of error. Rev Med Virol. 2019;29(4):e2052.","journal-title":"Rev Med Virol"},{"issue":"8","key":"2762_CR15","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1093\/cid\/ciw001","volume":"62","author":"T Roberts","year":"2016","unstructured":"Roberts T, Cohn J, Bonner K, Hargreaves S. Scale-up of routine viral load testing in resource-poor settings: current and future implementation challenges. Clin Infect Dis. 2016;62(8):1043\u20138.","journal-title":"Clin Infect Dis"},{"issue":"8","key":"2762_CR16","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1093\/cid\/ciw001","volume":"62","author":"TCJ Roberts","year":"2016","unstructured":"Roberts TCJ, Bonner K, Hargreaves S. Scale-up of routine viral load testing in resource-poor settings: current and future implementation challenges. Clin Infect Dis. 2016;62(8):1043\u20138.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"2762_CR17","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3352\/jeehp.2021.18.17","volume":"18","author":"H Kang","year":"2021","unstructured":"Kang H. Sample size determination and power analysis using the G* power software. Educ Eval Health Prof. 2021;18(1):17.","journal-title":"Educ Eval Health Prof"},{"key":"2762_CR18","first-page":"1","volume-title":"National consolidated guidelines for comprehensive HIV prevention, care and treatment","author":"Federal Ministry of Health","year":"2018","unstructured":"Federal Ministry of Health. National consolidated guidelines for comprehensive HIV prevention, care and treatment. Addis Ababa, Ethiopia.: Federal Ministry of Health; 2018. pp. 1\u2013238."},{"issue":"1","key":"2762_CR19","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.2147\/PPA.S268395","volume":"14","author":"AA Desta","year":"2020","unstructured":"Desta AA, Kidane KM, Woldegebriel AG, Ajemu KF, Berhe AA, Zgita DN, et al. Level of adherence and associated factors among HIV-infected patients on antiretroviral therapy in Northern Ethiopia: retrospective analysis. Patient Prefer Adherence. 2020;14(1):1585\u201394.","journal-title":"Patient Prefer Adherence"},{"issue":"2","key":"2762_CR20","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jcv.2012.06.010","volume":"55","author":"SKS Masciotra","year":"2012","unstructured":"Masciotra SKS, Bil\u00e9 E, Puren A, Fonjungo P, Nguyen S, et al. Evaluation of blood collection filter papers for HIV-1 DNA PCR. J Clin Virol. 2012;55(2):101\u20136.","journal-title":"J Clin Virol"},{"issue":"4","key":"2762_CR21","first-page":"188","volume":"31","author":"YC Tung","year":"2015","unstructured":"Tung YC, Ke LY, Lu PL, Lin KH, Lee SC, Lin YY, et al. Comparison of the Roche COBAS Ampli-Prep\/COBAS Taq man HIV-1 test v1.0 with v2.0 in HIV-1 viral load quantification. J Med Sci. 2015;31(4):188\u201393.","journal-title":"J Med Sci"},{"issue":"1","key":"2762_CR22","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jcv.2010.06.004","volume":"49","author":"D Sizmann","year":"2010","unstructured":"Sizmann D, Glaubitz J, Simon CO, Goedel S, Buergisser P, Drogan D, et al. Improved HIV-1 RNA quantitation by COBAS\u00ae AmpliPrep\/COBAS\u00ae TaqMan\u00ae HIV-1 test, v2. 0 using a novel dual-target approach. J Clin Virol. 2010;49(1):41\u20136.","journal-title":"J Clin Virol"},{"issue":"Supplement1","key":"2762_CR23","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1086\/650390","volume":"201","author":"A Puren","year":"2010","unstructured":"Puren A, Gerlach JL, Weigl BH, Kelso DM, Domingo GJ. Laboratory operations, specimen processing, and handling for viral load testing and surveillance. J Infect Dis. 2010;201(Supplement1):S27\u201336.","journal-title":"J Infect Dis"},{"key":"2762_CR24","volume-title":"Clinical virology manual","author":"R Khare","year":"2016","unstructured":"Khare R, Grys TE. Specimen requirements selection, collection, transport, and processing. In: Michael J, Loeffelholz RLH, Stephen A, Young BA, Pinsky, editors. Clinical virology manual. United Kingdom: Bloomsbury Publishing Plc.; 2016."},{"key":"2762_CR25","unstructured":"World Health Organization. HIV and, Geneva AIDS. Switzerland: World Health Organization; 2023 [updated 22 July, 2024. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hiv-aids"},{"issue":"3","key":"2762_CR26","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/CMR.00097-18","volume":"32","author":"PKDJ Drain","year":"2019","unstructured":"Drain PKDJ, Bender A, Lillis L, Marinucci F, Sacks J, et al. Point-of-care HIV viral load testing: an essential tool for a sustainable global HIV\/AIDS response. Clin Microbiol Rev. 2019;32(3):10\u2013128.","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"2762_CR27","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1186\/s12889-022-13504-2","volume":"22","author":"MDNH Pham","year":"2022","unstructured":"Pham MDNH, Anderson D, Crowe S, Luchters S. Viral load monitoring for people living with HIV in the era of test and treat: progress made and challenges ahead\u2013a systematic review. BMC Public Health. 2022;22(1):1203.","journal-title":"BMC Public Health"},{"key":"2762_CR28","doi-asserted-by":"crossref","unstructured":"Lecher SLJMM. report mw. HIV viral load monitoring among patients receiving antiretroviral therapy\u2014eight sub-Saharan Africa countries, 2013\u20132018. United States of America: Centers for Disease Control and Prevention; 2021. Contract No.: 21.","DOI":"10.15585\/mmwr.mm7021a2"},{"issue":"3","key":"2762_CR29","doi-asserted-by":"publisher","first-page":"e0282652","DOI":"10.1371\/journal.pone.0282652","volume":"18","author":"PNLS Fonjungo","year":"2023","unstructured":"Fonjungo PNLS, Zeh C, Rottinghaus E, Chun H, Adje-Toure C, et al. Progress in scale up of HIV viral load testing in select sub-Saharan African countries 2016\u20132018. PLoS ONE. 2023;18(3):e0282652.","journal-title":"PLoS ONE"},{"issue":"2","key":"2762_CR30","doi-asserted-by":"publisher","first-page":"e0264441","DOI":"10.1371\/journal.pone.0264441","volume":"17","author":"SMZ Lulseged","year":"2022","unstructured":"Lulseged SMZ, Habteselassie A, West CA, Gelibo T, Belete W, et al. Progress towards controlling the HIV epidemic in urban Ethiopia: findings from the 2017\u20132018 Ethiopia population-based HIV impact assessment survey. PLoS ONE. 2022;17(2):e0264441.","journal-title":"PLoS ONE"},{"issue":"1","key":"2762_CR31","doi-asserted-by":"publisher","first-page":"1933788","DOI":"10.1080\/16549716.2021.1933788","volume":"14","author":"MPC Johansson","year":"2021","unstructured":"Johansson MPC, Winqvist N, Tesfaye F, Bj\u00f6rkman P. How does HIV testing modality impact the cascade of care among persons diagnosed with HIV in Ethiopia? Global Health Action. 2021;14(1):1933788.","journal-title":"Global Health Action"},{"key":"2762_CR32","doi-asserted-by":"publisher","unstructured":"Drain PKDJ, Bender A, Lillis L, Marinucci F, Sacks J, et al. Point-of-care HIV viral load testing: an essential tool for a sustainable global HIV\/AIDS response. Clin Microbiol Rev. 2019;32(3). https:\/\/doi.org\/10.1128\/cmr. 00097\u2013\u200918.","DOI":"10.1128\/cmr"},{"issue":"5","key":"2762_CR33","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S1473-3099(12)70314-6","volume":"13","author":"WCPK Miller","year":"2013","unstructured":"Miller WCPK, Smith MK, Cohen MS. Community viral load as a measure for assessment of HIV treatment as prevention. Lancet Infect Dis. 2013;13(5):459\u201364.","journal-title":"Lancet Infect Dis"},{"issue":"15","key":"2762_CR34","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.1097\/QAD.0000000000004035","volume":"38","author":"DMS Paraskevis","year":"2024","unstructured":"Paraskevis DMS. Self-collected or staff-collected dried blood spot specimens for HIV-1 viral load testing. AIDS. 2024;38(15):2098\u20139.","journal-title":"AIDS"},{"key":"2762_CR35","doi-asserted-by":"crossref","unstructured":"al. VMSSRSSSWGMKSSe. Dried blood spots versus plasma for the quantitation of HIV-1 RNA using a real-Time PCR, m2000rt assay. Virological Methods. 2012;181(2):177\u201381.","DOI":"10.1016\/j.jviromet.2012.02.006"},{"key":"2762_CR36","doi-asserted-by":"crossref","unstructured":"Mbida AD, Sosso S, Flori P, Saoudin H, Lawrence P, Monny-Lob\u00e9 M. ea. Measure of viral load by using the Abbott Real-Time HIV-1 assay on dried blood and plasma spot specimens collected in 2 rural dispensaries in Cameroon. Journal of Acquired Immune Deficiency Syndromes. 2009;52(1):9\u201316.","DOI":"10.1097\/QAI.0b013e3181aeccbc"},{"issue":"4","key":"2762_CR37","doi-asserted-by":"publisher","first-page":"403","DOI":"10.4103\/0255-0857.103759","volume":"30","author":"R DSSJJJPSK","year":"2012","unstructured":"DSSJJJPSK R. Comparison of HIV-1 RNA level estimated with plasma and DBS samples: a pilot study from India (South). Ind J Med Microbiol. 2012;30(4):403\u20136.","journal-title":"Ind J Med Microbiol"},{"issue":"6","key":"2762_CR38","first-page":"956","volume":"136","author":"al NUGSRRSPRSRBe","year":"2012","unstructured":"NUGSRRSPRSRBe. al. Dried blood spot HIV-1 RNA quantification: a useful tool for viral load monitoring among HIV-infected individuals in India. Indian J Med Res. 2012;136(6):956\u201362.","journal-title":"Indian J Med Res"},{"key":"2762_CR39","doi-asserted-by":"crossref","unstructured":"al. REURDKBOAADJe. Dried blood spot specimens are a suitable alternative sample type for HIV-1 viral load measurement and drug resistance genotyping in patients receiving first-line antiretroviral therapy. Clin Infect Dis. 2012;54(8):1187\u201395.","DOI":"10.1093\/cid\/cis015"},{"issue":"4","key":"2762_CR40","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1128\/JCM.02099-08","volume":"47","author":"C GCZNCAAMSVdM","year":"2009","unstructured":"GCZNCAAMSVdM C. Correlation between human immunodeficiency virus type 1 (HIV-1) RNA measurements obtained with dried blood spots and those obtained with plasma by use of nuclisens EasyQ HIV-1 and Abbott realtime HIV load tests. Clin Microbiol. 2009;47(4):1031\u20136.","journal-title":"Clin Microbiol"},{"issue":"2","key":"2762_CR41","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jviromet.2008.09.022","volume":"155","author":"N LWYNCTOCCMV","year":"2009","unstructured":"LWYNCTOCCMV. N. Dried blood spots for the diagnosis and quantitation of HIV-1: stability studies and evaluation of sensitivity and specificity for the diagnosis of infant HIV-1 infection in Thailand. Virological Methods. 2009;155(2):109\u201317.","journal-title":"Virological Methods"},{"issue":"4","key":"2762_CR42","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1097\/QAI.0000000000001275","volume":"74","author":"J SMASJMBLKMO","year":"2017","unstructured":"SMASJMBLKMO J. Field evaluation of dried blood spots for HIV-1 viral load monitoring in adults and children receiving antiretroviral treatment in Kenya: implications for scale-up in resource-limited settings. Acquir Immune Defic Syndr. 2017;74(4):399\u2013406.","journal-title":"Acquir Immune Defic Syndr"},{"issue":"3","key":"2762_CR43","first-page":"75","volume":"7","author":"al. OEADMRK-wLKGBSe","year":"2017","unstructured":"al. OEADMRK-wLKGBSe. Evaluation of dried blood spots as an alternative sample type in HIV-1 RNA quantification from patients receiving anti-retroviral treatment in Kenya. Clin Med Diagn. 2017;7(3):75\u20139.","journal-title":"Clin Med Diagn"},{"issue":"6","key":"2762_CR44","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1086\/605502","volume":"49","author":"A Johannessen","year":"2009","unstructured":"Johannessen A, Garrido C, Zahonero N, Sandvik L, Naman E, KSea. Dried blood spots perform well in viral load monitoring of patients who receive antiretroviral treatment in rural Tanzania. Clin Infect Dis. 2009;49(6):976\u201381.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"2762_CR45","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.arcmed.2005.03.010","volume":"36","author":"A-MMZ-RSR-MOP-SGV-RGG-DAe","year":"2005","unstructured":"A-MMZ-RSR-MOP-SGV-RGG-DAe. High correlation of human immunodeficiency virus type-1 viral load measured in dried-blood spot samples and in plasma under different storage conditions. Arch Med Res. 2005;36(4):382\u20136.","journal-title":"Arch Med Res"},{"key":"2762_CR46","doi-asserted-by":"crossref","unstructured":"al. AMPMGGCSPGGPe. Correlation between HIV-1 viral load quantification in plasma, dried blood spots, and dried plasma spots using the Roche COBAS Taqman assay. J Clin Virol. 2010;47(1):4\u20137.","DOI":"10.1016\/j.jcv.2009.11.006"},{"issue":"4","key":"2762_CR47","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.jcv.2014.05.005","volume":"60","author":"SE Rutstein","year":"2014","unstructured":"Rutstein SE, Kamwendo D, Lugali L, Thengolose I, Tegha G. Fiscus SA Ea. Measures of viral load using Abbott realtime HIV-1 assay on venous and fingerstick dried blood spots from provider-collected specimens in Malawian district hospitals. J Clin Virol. 2014;60(4):392\u20138.","journal-title":"J Clin Virol"},{"issue":"2","key":"2762_CR48","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.jcv.2009.11.021","volume":"47","author":"P Van Deursen","year":"2010","unstructured":"Van Deursen P, Oosterlaken T, Andre P, Verhoeven A, Bertens L. Trabaud MA Eal. Measuring human immunodeficiency virus type 1 RNA loads in dried blood spot specimens using nuclisens EasyQ HIV-1 v2. 0. J Clin Virol. 2010;47(2):120\u20135.","journal-title":"J Clin Virol"},{"issue":"1","key":"2762_CR49","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.jviromet.2009.06.002","volume":"161","author":"HJ. RSSMA-LVF","year":"2009","unstructured":"HJ. RSSMA-LVF. Quantitation of HIV-1 RNA in dried blood and plasma spots. J Virol Methods. 2009;161(1):177\u201380.","journal-title":"J Virol Methods"},{"issue":"5","key":"2762_CR50","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1111\/hiv.13610","volume":"25","author":"HB Krentz","year":"2024","unstructured":"Krentz HB, Lang R, McMillan J, Ody M, Gill MJ. The changing landscape of both causes and locations of death in a regional HIV population 2010\u20132021. HIV Med. 2024;25(5):608\u201313.","journal-title":"HIV Med"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-025-02762-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12985-025-02762-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-025-02762-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T11:39:27Z","timestamp":1747309167000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-025-02762-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,15]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2762"],"URL":"https:\/\/doi.org\/10.1186\/s12985-025-02762-2","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,15]]},"assertion":[{"value":"30 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The current study was performed after obtaining ethical approval from the ethics committee of the Institute of Biotechnology, University of Gondar, Gondar, Ethiopia. Written informed consent and informed assent were obtained from all study participants and parents\/guardians of study participants under 18 years of age, respectively. The confidentiality of the participant\u2019s data was kept by assigning a unique code to each study participant, and the study was conducted as per the Helsinki Declaration for Biomedical Research.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"145"}}